Agonist activation of the G protein‐coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β‐arrestin‐2
Open Access
- 20 October 2010
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 162 (3) , 733-748
Abstract
BACKGROUND AND PURPOSE: GPR35 is a poorly characterized G protein‐coupled receptor at which kynurenic acid has been suggested to be the endogenous ligand. We wished to test this and develop assays appropriate for the study of this receptor.EXPERIMENTAL APPROACH: Human and rat orthologues of GPR35 were engineered and expressed and assays developed to assess interaction with β‐arrestin‐2, activation of Gα13 and agonist‐induced internalization.KEY RESULTS: GPR35‐β‐arrestin‐2 interaction assays confirmed that both the endogenous tryptophan metabolite kynurenic acid and the synthetic ligand zaprinast had agonist action at each orthologue. Zaprinast was substantially more potent than kynurenic acid at each and both agonists displayed substantially greater potency at rat GPR35. Two novel thiazolidinediones also displayed agonism and displayed similar potency at each GPR35 orthologue. The three ligand classes acted orthosterically with respect to each other, suggesting overlapping binding sites and, consistent with this, mutation to alanine of the conserved arginine at position 3.36 or tyrosine 3.32 in transmembrane domain III abolished β‐arrestin‐2 recruitment in response to each ligand at each orthologue.CONCLUSIONS AND IMPLICATIONS: These studies indicate that β‐arrestin‐2 interaction assays are highly appropriate to explore the pharmacology of GPR35 and that Gα13 activation is an alternative avenue of signal generation from GPR35. Arginine and tyrosine residues in transmembrane domain III are integral to agonist recognition and function of this receptor. The potency of kynurenic acid at human GPR35 is sufficiently low, however, to question whether it is likely to be the true endogenous ligand for this receptor.Keywords
This publication has 47 references indexed in Scilit:
- Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3British Journal of Pharmacology, 2009
- Kynurenic Acid Triggers Firm Arrest of Leukocytes to Vascular Endothelium under Flow ConditionsJournal of Biological Chemistry, 2009
- The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1Journal of Biological Chemistry, 2009
- Lipid G Protein-coupled Receptor Ligand Identification Using β-Arrestin PathHunter™ AssayJournal of Biological Chemistry, 2009
- IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channelsNucleic Acids Research, 2008
- G Protein–Coupled Receptor Sorting to Endosomes and LysosomesAnnual Review of Pharmacology and Toxicology, 2008
- GPR35 is a functional receptor in rat dorsal root ganglion neuronsBiochemical and Biophysical Research Communications, 2008
- The orphan receptor GPR55 is a novel cannabinoid receptorBritish Journal of Pharmacology, 2007
- Novel cannabinoid receptorsBritish Journal of Pharmacology, 2007
- Chimaeric Gα proteins: their potential use in drug discoveryTrends in Pharmacological Sciences, 1999